Why the study?
Does methanol extract of Cussonia arborea reduce fasting blood glucose and glycosylated haemoglobin in alloxan-induced diabetic rats?
Does methanol extract of Cussonia arborea reduce fasting blood glucose and glycosylated haemoglobin in alloxan-induced diabetic rats?
Methanol extract of Cussonia arborea at 125 mg/kg effectively reduces fasting blood glucose and mitigates haemoglobin glycosylation in a rat model of diabetes.
Hypothesis-generating for Cussonia arborea in diabetes models; leaves open human translation.
This study investigated glycosylated haemoglobin values and fasting blood glucose (FBG) levels of diabetic rats treated with methanol extract of Cussonia arborea. A total of 72 male wistar rats were assigned into 6 groups of 12 rats per group. Groups 1–5 rats were made diabetic by intraperitoneal injection of alloxan monohydrate at the dose of 160 mg/kg and treated with 62.5, 125, 250 mg/kg of the extracts, 2 mg/kg glibenclamide and 10 ml/kg distilled water (DW), respectively, while the non-diabetic group 6 rats received 10 ml/kg DW and served as normal control rats. The treatment was daily through the oral route for 84 days. The glycosylated haemoglobin values were measured on days 42, 56 and 84 post treatment while the FBG levels were determined on 2 weeks interval post treatment till the end of the experiment. The mean FBG level of rats treated with 125 mg/kg of the extract showed the most significant reduction (p < .05) in FBG from 315.33 ± 10.08 mg/dl to 93.00 ± 8.50 mg/dl and equally ameliorated haemoglobin glycosylation when compared to the negative control group. It was concluded that the methanol extract of C.arborea, at the dose of 125 mg/kg mitigated glycosylation of haemoglobin.
No takes yet. Share an insight, caveat, or question.
Emeka et al. (2018) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: